UBS Group AG Raises Stock Position in Astrana Health, Inc. $ASTH

UBS Group AG raised its stake in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 48.4% during the fourth quarter, Holdings Channel reports. The firm owned 176,100 shares of the company’s stock after buying an additional 57,432 shares during the quarter. UBS Group AG’s holdings in Astrana Health were worth $4,369,000 at the end of the most recent quarter.

A number of other hedge funds have also added to or reduced their stakes in the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Astrana Health by 79.4% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,144 shares of the company’s stock valued at $376,000 after purchasing an additional 6,702 shares during the period. State of Alaska Department of Revenue increased its position in Astrana Health by 24.8% during the 4th quarter. State of Alaska Department of Revenue now owns 30,546 shares of the company’s stock valued at $757,000 after purchasing an additional 6,071 shares during the period. Signaturefd LLC increased its position in Astrana Health by 57.9% during the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the period. Yarbrough Capital LLC purchased a new position in Astrana Health during the 4th quarter valued at $394,000. Finally, NorthCrest Asset Manangement LLC increased its position in Astrana Health by 0.5% during the 4th quarter. NorthCrest Asset Manangement LLC now owns 450,465 shares of the company’s stock valued at $12,343,000 after purchasing an additional 2,084 shares during the period. 52.77% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Zacks Research raised shares of Astrana Health from a “strong sell” rating to a “hold” rating in a research report on Wednesday, March 11th. Truist Financial upped their target price on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a research report on Thursday, May 14th. Needham & Company LLC upped their target price on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Barclays upped their target price on shares of Astrana Health from $26.00 to $37.00 and gave the stock an “equal weight” rating in a research report on Monday, May 11th. Finally, TD Cowen upped their target price on shares of Astrana Health from $35.00 to $45.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. Six investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $43.14.

Astrana Health Stock Up 1.3%

NASDAQ:ASTH opened at $37.85 on Friday. The firm’s 50-day moving average price is $30.70 and its 200-day moving average price is $26.17. The company has a market capitalization of $2.11 billion, a PE ratio of 62.05 and a beta of 0.98. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. Astrana Health, Inc. has a 1-year low of $18.08 and a 1-year high of $39.93.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, May 7th. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.29 by $0.45. The firm had revenue of $965.10 million for the quarter, compared to the consensus estimate of $949.21 million. Astrana Health had a net margin of 0.86% and a return on equity of 9.22%. The company’s revenue was up 55.6% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.42 EPS. On average, equities analysts predict that Astrana Health, Inc. will post 1.25 EPS for the current fiscal year.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.